<DOC>
	<DOCNO>NCT01197183</DOCNO>
	<brief_summary>This observational survey prospective and/or retrospective follow-up design study practice initial treatment hypothyroidism France without modify subject treatment .</brief_summary>
	<brief_title>Observational Study With Prospective and/or Retrospective Follow-up , Without Modifying Patient Treatment Follow-up Practices Initial Treatment Hypothyroidism France</brief_title>
	<detailed_description>Thyroid disorder central , cause deficiency thyroid stimulate hormone ( TSH ) production ; peripheral , cause decrease plasma concentration thyroid hormone , specifically free thyroxine ( free T4 ) . Peripheral hypothyroidism cause decrease production capacity thyroid gland . The treatment hypothyroidism base restoration maintenance biological ( judged basis standardise TSH T4 value ) clinical euthyroidism . A number form thyroid hormone available French market ( Euthyral® , Cynomel® , L-thyroxine drops® ) , , Levothyrox® frequently prescribe drug category . The treatment peripheral hypothyroidism , particular , well codify almost consensual . In France , publish observational study , base one document manner subject treat . This observational study set document practice . OBJECTIVES The principal objective survey get information use Levothyrox France - Circumstances diagnosis - Record realise - Terms condition treatment general practitioner and/or endocrinologist The secondary objective evaluate inclusion criterion levothyroxine treatment . For subject participate doctor complete follow questionnaire form first control level TSH diagnosis hypothyroidism .</detailed_description>
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>Recently diagnose hypothyroid subject ( either inclusion period , within 6 previous month ) , data relate diagnosis available diagnosis carry initially investigate doctor Subject , give his/her oral consent participation Subject include clinical trial participate clinical trial last 3 month Subject present major objectifiable risk able followup next TSH level ( move , problem encounter another study , pathology affect vital prognosis shortterm ) All contraindication Lévothyrox</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Hypothyroidism</keyword>
	<keyword>Thyroid hormone</keyword>
</DOC>